Assessment of N-95 Facemask for Use in COVID-19 Pandemic in Case of Shortage of Personal Protective Equipment

Sponsor
University of Oklahoma (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT04416919
Collaborator
US Department of Veterans Affairs (U.S. Fed)
20
1
1
13.4
1.5

Study Details

Study Description

Brief Summary

The purpose of this study is to assess the safety and efficiency of an assembled modified mask in protecting health care workers against Coronavirus in case of any personal protective equipment shortage. At least 20 healthy participants will be recruited to try the modified mask. The modified masks will be made from masks that are already available as well as filters available in the pulmonary department at the Oklahoma City VA Health Care System

Condition or Disease Intervention/Treatment Phase
  • Other: Assembled mask
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
A Proposed Alternative to the N-95 Mask Shortage in the COVID-19 Pandemic. A Feasibility Study
Actual Study Start Date :
May 20, 2020
Actual Primary Completion Date :
Jun 1, 2020
Anticipated Study Completion Date :
Jul 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Other: Assembled Mask

Participant will be fitted with a full-face mask that covers the mouth and nose or a Whole face mask that covers the eyes, nose, and mouth depending on participant's preferences. The Fitted Mask will be attached to a bacterial/viral filter for fit testing. After completing the Fit test, the mask will be placed on the face for 15 minutes while the participant performs various activities to document the ability to tolerate the respirator. Participants oxygen and carbon dioxide level will be measured in the beginning and at the end of the 15 minutes. The individuals will be able to remove the Mask anytime if they experience significant discomfort or claustrophobia. At the end, the mask will be removed.

Other: Assembled mask
Assembled masks consisting of 3 parts: A facemask (Respironics Performax Whole Face Mask or Hans Rudolph mask naso-oral mask) linked by a blue elbow ( RP Performax SE ELBOW) to a ventilator filter (Teleflex Bacterial/Viral filter 1605 or Iso-Gard HEPA light Filter 28022)

Outcome Measures

Primary Outcome Measures

  1. Success Percentage [15 minutes]

    Conduct a quantitative fit test and calculate the percentage of participants who pass the test.

Secondary Outcome Measures

  1. End-tidal CO2 Variation. Description: mmHg. [at 0 and 15 minutes]

    Change in end-tidal CO2 from 0 to 15 minutes while wearing the Full or the Whole mask

  2. Oxygen Pulse Oximetry Variation. Description: mmHg. [at 0 and 15 minutes.]

    Measure the change in Oxygen Pulse Oximetry from 0 to15 minutes while wearing the Full or the Whole mask

  3. Mask Visibility. Description: Likert Scale. [15 minutes]

    Evaluate the visibility (5-point Likert scale from Absent to Complete) while wearing the Full or the Whole mask for 15 minutes

  4. Willingness of usage. Description: Likert Scale. [after 15 minutes]

    When the mask is removed, participants will be asked about willingness to use this mask compared to N-95 masks using a 5-point Likert scale from 'Very unlikely' to 'Very likely'.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. All individuals older than 18 years of age, and willing to participate in the study
Exclusion Criteria:
  1. Individuals with known severe COPD/emphysema, Obesity Hypoventilation or hypercapnic condition

  2. Individuals with allergy or reactions to latex or masks

  3. Individuals reporting dyspnea or unable to breathe comfortably in these masks

  4. Claustrophobic individuals

  5. Inability to create a proper Seal while inhaling through a closed filter (See Below)

  6. Individuals who cannot safely apply and remove these masks

Contacts and Locations

Locations

Site City State Country Postal Code
1 Oklahoma City VA Health Care System Oklahoma City Oklahoma United States 73104

Sponsors and Collaborators

  • University of Oklahoma
  • US Department of Veterans Affairs

Investigators

  • Principal Investigator: Houssein Youness, MD, University of Oklahoma HSC - OKC Veterans Affairs Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
University of Oklahoma
ClinicalTrials.gov Identifier:
NCT04416919
Other Study ID Numbers:
  • 11887
First Posted:
Jun 4, 2020
Last Update Posted:
Mar 5, 2021
Last Verified:
Mar 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Oklahoma
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 5, 2021